PPA
IDXX icon

Pilgrim Partners Asia’s Idexx Laboratories IDXX Stock Holding History

Pilgrim Partners Asia’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$42K Sell
100
-160
-62% -$69.5K 0.04% 95
2024
Q4 		$107K Buy
+260
New +$114K 0.09% 48

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Pilgrim Partners Asia's IDXX Position: Q1 2025 in Review

Pilgrim Partners Asia reduced its Idexx Laboratories (IDXX) stake by 62% in Q1 2025, selling an estimated $69.5K and leaving 100 shares worth $42K. The position accounts for 0.04% of the portfolio, ranked #95.

Pilgrim Partners Asia first reported a position in IDXX in Q4 2024 and has held it in 2 quarters since. The position peaked at $107K in Q4 2024. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Pilgrim Partners Asia held 100 shares of Idexx Laboratories worth $42K as of Q1 2025.
  • Pilgrim Partners Asia sold 160 Idexx Laboratories shares in Q1 2025, an estimated $69.5K.
  • Idexx Laboratories made up 0.04% of Pilgrim Partners Asia's portfolio in Q1 2025, its #95 holding.
  • Pilgrim Partners Asia first reported a position in Idexx Laboratories in Q4 2024 and has held it in 2 quarters since.
  • Pilgrim Partners Asia's Idexx Laboratories position peaked at $107K in Q4 2024.
  • 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Pilgrim Partners Asia's 13F filing for Q1 2025, filed 14 May 2025.